Sarissa Capital Management as of June 30, 2023
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS (ALKS) | 43.7 | $440M | 14M | 31.30 | |
| Biogen Idec (BIIB) | 18.2 | $183M | 643k | 284.85 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 17.4 | $174M | 16M | 10.64 | |
| Innoviva (INVA) | 9.2 | $93M | 7.3M | 12.73 | |
| Gilead Sciences (GILD) | 7.1 | $71M | 920k | 77.07 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $22M | 231k | 94.30 | |
| Mersana Therapeutics (MRSN) | 0.9 | $8.7M | 2.6M | 3.29 | |
| Amarin Corp Spons Adr New (AMRN) | 0.6 | $5.8M | 4.9M | 1.19 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $5.5M | 775k | 7.04 | |
| Vor Biopharma (VOR) | 0.2 | $1.9M | 618k | 3.09 | |
| Regulus Therapeutics (RGLS) | 0.0 | $272k | 185k | 1.47 |
